Transplant Complications Working Party (TCWP)
Type of Stem Cell Treatment:
CAR T cell outcomes in patients with comorbidities
To determine the cumulative incidence of early non-relapse mortality (NRM) of the CAR-T cell therapies in relation to presence of specific comorbid conditions.
Key inclusion criteria:
This is a retrospective multicentre analysis using the data of the GoCART coalition. Eligibility criteria for this analysis include all patients that underwent CAR T-cell therapy in an EBMT member centre.